PepsiCo Running Out of Time to Meet Elliott-Inspired Targets as GLP-1 Threat Intensifies
Reuters reports that PepsiCo is facing a tight deadline to achieve the goals set by activist investor Elliott, as the growing threat from GLP-1 (glucagon-like peptide-1) drugs intensifies.